In 2006, the renowned German MIG Fonds completed their funding series, followed by funding series B in 2008. In 2007, Biocrates progressed from a limited liability company to a joint stock company. Since its inception, Biocrates has been a strong participant in national and international funding projects. Funding series C is currently open for selected investors. The existing syndicate of investors have contributed significantly to this series: